
|Articles|November 1, 2007
B&L merger approved
Bausch & Lomb's shareholders have voted to approve a merger with Warburg Pincus.
Advertisement
Bausch & Lomb's shareholders have voted to approve a merger with Warburg Pincus.
In accordance with the terms of the merger, each outstanding share of common and Class B stock will be cancelled and converted into the right to receive $65 in cash, without interest, less any applicable withholding taxes.
The merger is expected to close early in the fourth quarter of this year.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
BL1332 misses primary end point in phase 2 post-PRK ocular pain study
2
FLORetina-ICOOR 2026: AI moves from the image to the trial, the clinic, and the operating room
3
Water-soluble CBD eye drops lower IOP and dampen corneal sensitivity in glaucoma mouse model
4
Q&A: GLP-1 RAs and NAION, the case for a baseline exam
5











